Literature DB >> 20022942

An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Sai K Buddai1, Juliana M Layzer, Genmin Lu, Christopher P Rusconi, Bruce A Sullenger, Dougald M Monroe, Sriram Krishnaswamy.   

Abstract

The interaction of factor Xa with factor Va on membranes to form prothrombinase profoundly increases the rate of the proteolytic conversion of prothrombin to thrombin. We present the characterization of an RNA aptamer (RNA(11F7t)) selected from a combinatorial library based on its ability to bind factor Xa. We show that RNA(11F7t) inhibits thrombin formation catalyzed by prothrombinase without obscuring the active site of Xa within the enzyme complex. Selective inhibition of protein substrate cleavage arises from the ability of the aptamer to bind to factor Xa and exclude interactions between the proteinase and cofactor within prothrombinase. Competition for enzyme complex assembly results from the binding of RNA(11F7t) to factor Xa with nanomolar affinity in a Ca(2+)-dependent interaction. RNA(11F7t) binds equivalently to the zymogen factor X as well as derivatives lacking gamma-carboxyglutamic acid residues. We suggest that the ability of RNA(11F7t) to compete for the Xa-Va interaction with surprisingly high affinity likely reflects a significant contribution from its ability to indirectly impact regions of Xa that participate in the proteinase-cofactor interaction. Thus, despite the complexity of the macromolecular interactions that underlie the assembly of prothrombinase, efficient inhibition of enzyme complex assembly and thrombin formation can be achieved by tight binding ligands that target factor Xa in a discrete manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022942      PMCID: PMC2820749          DOI: 10.1074/jbc.M109.049833

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Blocking the initiation of coagulation by RNA aptamers to factor VIIa.

Authors:  C P Rusconi; A Yeh; H K Lyerly; J H Lawson; B A Sullenger
Journal:  Thromb Haemost       Date:  2000-11       Impact factor: 5.249

2.  Generation of species cross-reactive aptamers using "toggle" SELEX.

Authors:  R White; C Rusconi; E Scardino; A Wolberg; J Lawson; M Hoffman; B Sullenger
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

3.  Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.

Authors:  Sai K Buddai; Larisa Toulokhonova; Peter W Bergum; George P Vlasuk; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

Review 4.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

Authors:  K G Mann; R J Jenny; S Krishnaswamy
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

5.  A monoclonal antibody which inhibits the factor Va:factor Xa interaction.

Authors:  M M Tucker; W B Foster; J A Katzmann; K G Mann
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

Review 6.  Prothrombin.

Authors:  K G Mann; J Elion; R J Butkowski; M Downing; M E Nesheim
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.

Authors:  R J Baugh; C D Dickinson; W Ruf; S Krishnaswamy
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

8.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

9.  Solution composition dependent variation in extinction coefficients for p-nitroaniline.

Authors:  R Lottenberg; C M Jackson
Journal:  Biochim Biophys Acta       Date:  1983-02-15

10.  Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.

Authors:  S P Bajaj; S I Rapaport; S F Brown
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

View more
  21 in total

1.  Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.

Authors:  Erin E Soule; Kristin M Bompiani; Rebecca S Woodruff; Bruce A Sullenger
Journal:  Nucleic Acid Ther       Date:  2015-11-19       Impact factor: 5.486

Review 2.  Modulation of the Coagulation Cascade Using Aptamers.

Authors:  Rebecca S Woodruff; Bruce A Sullenger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-27       Impact factor: 8.311

3.  A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Authors:  K-A Steen Burrell; J Layzer; B A Sullenger
Journal:  J Thromb Haemost       Date:  2017-08-02       Impact factor: 5.824

4.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

5.  Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.

Authors:  Kristin M Bompiani; Jens L Lohrmann; George A Pitoc; James W Frederiksen; George B Mackensen; Bruce A Sullenger
Journal:  Chem Biol       Date:  2014-07-24

6.  A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.

Authors:  K M Bompiani; D M Monroe; F C Church; B A Sullenger
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

Review 7.  Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.

Authors:  Maryam Tabarzad; Marzieh Jafari
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

8.  Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex.

Authors:  Manjunath Goolyam Basavaraj; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

9.  Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.

Authors:  Kenneth A Botkjaer; Elena I Deryugina; Daniel M Dupont; Henrik Gårdsvoll; Erin M Bekes; Cathrine K Thuesen; Zhuo Chen; Zhou Chen; Michael Ploug; James P Quigley; Peter A Andreasen
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

10.  The influence of hindered transport on the development of platelet thrombi under flow.

Authors:  Karin Leiderman; Aaron L Fogelson
Journal:  Bull Math Biol       Date:  2012-10-25       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.